Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the...

Area of Science:

• Cardiology
• Molecular Biology
• Cell Biology

Background:

• Stromal cell-derived factor-1alpha (SDF-1alpha) binding to CXCR4 regulates cellular functions.
• The role of the SDF-1alpha-CXCR4 axis in myocardial ischemia/reperfusion injury was previously unknown.

Purpose of the Study:

• To investigate the role of the SDF-1alpha-CXCR4 axis in myocardial ischemia/reperfusion injury.
• To determine if SDF-1alpha confers protection against cardiac ischemia/reperfusion damage.

Main Methods:

• Assessed SDF-1alpha and CXCR4 expression in mouse hearts and cultured cardiac myocytes and fibroblasts.
• Investigated the effects of SDF-1alpha on intracellular signaling pathways (ERK, AKT, JNK, p38) in myocytes.
• Evaluated the protective effects of SDF-1alpha against hypoxia/reoxygenation damage in vitro and ischemia/reperfusion injury in vivo.
• Utilized the CXCR4 antagonist AMD3100 to block SDF-1alpha effects.

Main Results:

• SDF-1alpha and CXCR4 are expressed in cardiac myocytes and fibroblasts, with SDF-1alpha increasing after hypoxic stimuli.
• SDF-1alpha activates ERK and AKT, and inhibits JNK and p38 in myocytes.
• SDF-1alpha pretreatment protected myocytes against hypoxia/reoxygenation damage, reducing cell death markers.
• In vivo, SDF-1alpha administration reduced infarct size following myocardial ischemia/reperfusion.
• The protective effects of SDF-1alpha were blocked by AMD3100 in both in vitro and in vivo models.

Conclusions:

• SDF-1alpha and CXCR4 form an axis in cardiac myocytes activated by preconditioning and hypoxia.
• This axis recruits antiapoptotic kinases ERK and AKT, promoting a protective program.
• The SDF-1alpha-CXCR4 axis confers protection against myocardial ischemia/reperfusion damage.